ISO 10993-3: Major Updates In Developmental & Reproductivity Toxicity (DART) Evaluation
The shift in ISO 10993-3 represents a fundamental change in how the industry approaches developmental and reproductive toxicity (DART). Rather than defaulting to exhaustive animal studies, the updated standard prioritizes a structured, data-driven framework. By placing chemical characterization and toxicological risk assessment at the forefront, manufacturers can evaluate genotoxicity and carcinogenicity with greater precision and efficiency.
Modernized study designs, such as OECD 443 and 422, are replacing traditional methods to better capture prenatal and systemic risks. Furthermore, the standard now places a necessary spotlight on endocrine disruptors, ensuring that even low-level hormonal interferences are identified through rigorous screening of extractables. This evolution moves the needle from simple compliance toward a proactive safety culture that protects vulnerable patient populations while reducing reliance on unnecessary in vivo testing.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.